Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Lomitapide, sold under the brand name Juxtapid in the US and Lojuxta in the EU, is a medication used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by Aegerion Pharmaceuticals. It has been tested in clinical trials as single treatment and in combinations with atorvastatin, ezetimibe and fenofibrate.
Overview, Mechanism of action & Side effects
Explore the main themes, entities and connections around Lomitapide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
us lipid-lowering familial hypercholesterolemia approved lipoprotein hofh fda drug treatment ldl name juxtapid lojuxta eu administration aegerion december 2012 homozygous
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Lomitapide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Lomitapide | ATC code | C10AX12 (WHO) | 1.00 | infobox |
| Lomitapide | CAS Number | 182431-12-5 Y | 1.00 | infobox |
| Lomitapide | CAS Number | mesylate: 202914-84-9 | 1.00 | infobox |
| Lomitapide | ChEBI | CHEBI:72297 N | 1.00 | infobox |
| Lomitapide | ChEBI | mesylate: CHEBI:72299 | 1.00 | infobox |
| Lomitapide | ChEMBL | ChEMBL354541 | 1.00 | infobox |
| Lomitapide | ChEMBL | mesylate: ChEMBL2105662 | 1.00 | infobox |
| Lomitapide | ChemSpider | 8028764 N | 1.00 | infobox |
| Lomitapide | ChemSpider | mesylate: 9449335 | 1.00 | infobox |
| Lomitapide | CompTox Dashboard (EPA) | DTXSID50171294 | 1.00 | infobox |
| Lomitapide | DrugBank | DB08827 Y | 1.00 | infobox |
| Lomitapide | DrugBank | mesylate: DBSALT000110 | 1.00 | infobox |
| Lomitapide | Formula | C39H37F6N3O2 | 1.00 | infobox |
| Lomitapide | IUPHAR/BPS | 7439 | 1.00 | infobox |
| Lomitapide | KEGG | D09637 Y | 1.00 | infobox |
| Lomitapide | KEGG | mesylate: D09638 | 1.00 | infobox |
| Lomitapide | Legal status | US: ℞-only | 1.00 | infobox |
| Lomitapide | Legal status | EU: Rx-only | 1.00 | infobox |
| Lomitapide | License data | EU EMA: by INN | 1.00 | infobox |
| Lomitapide | License data | US DailyMed: Lomitapide | 1.00 | infobox |
| Lomitapide | License data | US FDA: Lomitapide | 1.00 | infobox |
| Lomitapide | Molar mass | 693.734 g·mol−1 | 1.00 | infobox |
| Lomitapide | Other names | AEGR-773, BMS-201038 | 1.00 | infobox |
| Lomitapide | PubChem CID | 9853053 | 1.00 | infobox |
| Lomitapide | PubChem CID | mesylate: 11274333 | 1.00 | infobox |
| Lomitapide | Routes of administration | By mouth | 1.00 | infobox |
| Lomitapide | Trade names | Juxtapid (US), Lojuxta (EU) | 1.00 | infobox |
| Lomitapide | UNII | 82KUB0583F | 1.00 | infobox |
| Lomitapide | UNII | mesylate: X4S83CP54E | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.